Page last updated: 2024-09-05

paromomycin and HIV

paromomycin has been researched along with HIV in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barragán, P; López-Velez, R; Olmo, M; Podzamczer, D	1
Croft, SL; Olliaro, P	1
Cho, J; Rando, RR	1

Reviews

1 review(s) available for paromomycin and HIV

Article	Year
Leishmaniasis chemotherapy--challenges and opportunities. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2011, Volume: 17, Issue:10 Topics: Anti-HIV Agents; Antiprotozoal Agents; Clinical Trials as Topic; Coinfection; Drug Discovery; HIV; HIV Infections; Humans; India; Leishmania; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Paromomycin; Research	2011

Article

Year

Leishmaniasis chemotherapy--challenges and opportunities.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2011, Volume: 17, Issue:10

Topics: Anti-HIV Agents; Antiprotozoal Agents; Clinical Trials as Topic; Coinfection; Drug Discovery; HIV; HIV Infections; Humans; India; Leishmania; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Paromomycin; Research

2011

Other Studies

2 other study(ies) available for paromomycin and HIV

Article	Year
Visceral Leishmaniasis treated with antimonials/paromomycin followed by itraconazole/miltefosine after standard therapy failures in a human immunodeficiency virus-infected patient. The American journal of tropical medicine and hygiene, 2010, Volume: 83, Issue:1 Topics: AIDS-Related Opportunistic Infections; HIV; HIV Infections; HIV-1; Humans; Itraconazole; Leishmaniasis; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Opportunistic Infections; Parasitic Sensitivity Tests; Paromomycin; Phosphorylcholine; Recurrence; Treatment Failure	2010
Specificity in the binding of aminoglycosides to HIV-RRE RNA. Biochemistry, 1999, Jun-29, Volume: 38, Issue:26 Topics: Anti-Bacterial Agents; Binding Sites; DNA Mutational Analysis; Fluorescent Dyes; Framycetin; Gene Products, rev; HIV; Paromomycin; Response Elements; rev Gene Products, Human Immunodeficiency Virus; Rhodamines; RNA, Viral	1999

Article

Year

Visceral Leishmaniasis treated with antimonials/paromomycin followed by itraconazole/miltefosine after standard therapy failures in a human immunodeficiency virus-infected patient.

The American journal of tropical medicine and hygiene, 2010, Volume: 83, Issue:1

Topics: AIDS-Related Opportunistic Infections; HIV; HIV Infections; HIV-1; Humans; Itraconazole; Leishmaniasis; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Opportunistic Infections; Parasitic Sensitivity Tests; Paromomycin; Phosphorylcholine; Recurrence; Treatment Failure

2010

Specificity in the binding of aminoglycosides to HIV-RRE RNA.

Biochemistry, 1999, Jun-29, Volume: 38, Issue:26

Topics: Anti-Bacterial Agents; Binding Sites; DNA Mutational Analysis; Fluorescent Dyes; Framycetin; Gene Products, rev; HIV; Paromomycin; Response Elements; rev Gene Products, Human Immunodeficiency Virus; Rhodamines; RNA, Viral

1999